US equities |
MU $1,078.20 ▲+3.12% SNDK $1,723.06 ▲+3.77% NVDA $237.07 ▼-0.90% AMD $643.04 ▼-0.98% SPCX $167.78 ▼-2.41% INTC $113.11 ▲+0.54% TSLA $375.74 ▼-1.30% AAPL $335.70 ▲+0.62%
FinancialContent

Lifecore Biomedical, Inc. - Common Stock (NQ:LFCR)

6.440 -0.010 (-0.16%)
Delayed Quote Updated: 12:40 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lifecore Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher ↗
U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% to 16,165.15. The S&P... 
Via Benzinga
Topics Economy Stocks
News headline image
US Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top Views ↗
U.S. stocks traded slightly lower this morning, ahead of interest-rate decision from the Federal Reserve. Following the market opening Wednesday, the Dow traded down 0.01% to 39,106.88 while the NASDAQ... 
Via Benzinga
Topics Economy Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Preview: Lifecore Biomedical's Earnings ↗
 
Via Benzinga
News headline image
Recap: Lifecore Biomedical Q3 Earnings ↗
 
Via Benzinga
News headline image
Preview: Lifecore Biomedical's Earnings ↗
 
Via Benzinga
News headline image
Analyst Ratings for Lifecore Biomedical ↗
 
Via Benzinga
News headline image
Why Lifecore Biomedical Shares Are Skyrocketing Today ↗
 
Via Benzinga
News headline image
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
Efforts now aligned toward the completion of its First Quarter Fiscal 2024 Report on Form 10-Q 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company’s Securities 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Top 5 Risk Off Stocks That May Explode This Quarter ↗
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Lifecore Biomedical Provides Business Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
U.S. Department of Justice Declines Prosecution 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Top 5 Risk Off Stocks That May Plunge In Q2 ↗
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
Lifecore Biomedical Q3 Misses Street Estimates, Explores 'Strategic Alternatives' ↗
Lifecore Biomedical Inc (NASDAQ: LFCR) reported a Q3 FY23 revenue decline of 26% Y/Y to $27.60 million, 
Via Benzinga
News headline image
Earnings Scheduled For June 1, 2023 ↗
Companies Reporting Before The Bell • Hormel Foods (NYSE:HRL) is likely to report quarterly earnings at $0.40 per share on revenue of $3.05 billion. 
Via Benzinga
News headline image
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
Going concern qualification is removed as a result of the $150 million new financing transaction announced last week 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Dow Drops Over 100 Points; Lowe's Earnings Top Views ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.40% to 33,154.99 while the NASDAQ fell 0.32%... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on Tuesday! 
Via InvestorPlace
News headline image
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >